1. Home
  2. BIAF vs GWAV Comparison

BIAF vs GWAV Comparison

Compare BIAF & GWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • GWAV
  • Stock Information
  • Founded
  • BIAF 2014
  • GWAV 2002
  • Country
  • BIAF United States
  • GWAV United States
  • Employees
  • BIAF N/A
  • GWAV N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • GWAV Packaged Foods
  • Sector
  • BIAF Health Care
  • GWAV Consumer Staples
  • Exchange
  • BIAF Nasdaq
  • GWAV Nasdaq
  • Market Cap
  • BIAF 14.5M
  • GWAV 14.4M
  • IPO Year
  • BIAF 2022
  • GWAV N/A
  • Fundamental
  • Price
  • BIAF $0.67
  • GWAV $0.41
  • Analyst Decision
  • BIAF Strong Buy
  • GWAV
  • Analyst Count
  • BIAF 1
  • GWAV 0
  • Target Price
  • BIAF $6.00
  • GWAV N/A
  • AVG Volume (30 Days)
  • BIAF 298.9K
  • GWAV 2.4M
  • Earning Date
  • BIAF 11-14-2024
  • GWAV 11-15-2024
  • Dividend Yield
  • BIAF N/A
  • GWAV N/A
  • EPS Growth
  • BIAF N/A
  • GWAV N/A
  • EPS
  • BIAF N/A
  • GWAV N/A
  • Revenue
  • BIAF $9,367,785.00
  • GWAV $33,918,197.00
  • Revenue This Year
  • BIAF $285.51
  • GWAV N/A
  • Revenue Next Year
  • BIAF $20.05
  • GWAV N/A
  • P/E Ratio
  • BIAF N/A
  • GWAV N/A
  • Revenue Growth
  • BIAF 2813.87
  • GWAV 3.89
  • 52 Week Low
  • BIAF $0.64
  • GWAV $0.29
  • 52 Week High
  • BIAF $3.62
  • GWAV $154.50
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 26.36
  • GWAV 38.42
  • Support Level
  • BIAF $0.64
  • GWAV $0.38
  • Resistance Level
  • BIAF $1.01
  • GWAV $0.46
  • Average True Range (ATR)
  • BIAF 0.07
  • GWAV 0.08
  • MACD
  • BIAF -0.01
  • GWAV -0.03
  • Stochastic Oscillator
  • BIAF 5.99
  • GWAV 11.05

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About GWAV Greenwave Technology Solutions Inc.

Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company's products are selling ferrous metal, which is used in the recycling and production of finished steel. It is categorized into heavy melting steel, plate and structural, and shredded scrap. and it also processes nonferrous metals such as aluminum, copper, stainless steel, nickel, brass, titanium, alloys, and mixed metal products.

Share on Social Networks: